AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8885738
Drug: Supine position
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supine position after epidural injection
Trial: 28790547
Drug: Tamsulosin 0.4
RxNorm normalized name: tamsulosin 0.4 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.4 mg in the morning for 28 days, analgesic (diclofenac 75 mg), high fluid intake
Trial: 28790547
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received analgesic (diclofenac 75 mg), high fluid intake
Trial: 23642125
Drug: Dexamethasone (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (12 mg administered in two syringes, 24 hours apart)
Trial: 23642125
Drug: Betamethasone (11.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betamethasone (11.4 mg administered in two syringes, 24 hours apart)
Trial: 21112155
Drug: Acamprosate 666
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acamprosate 666 mg three times daily
Trial: 19623836
Drug: Single-dose antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose antibiotic prophylaxis (cephalexin, gentamycin, cephazolin)
Trial: 8622022
Drug: CMF-based adjuvant
RxNorm normalized name: Rna-based adjuvant cv8102
DrugBank: CV-8102 (DB19184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CMF-based adjuvant chemotherapy
Trial: 7848882
Drug: Local-regional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local-regional treatment alone
Trial: 7848882
Drug: CMF-based chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CMF-based chemotherapy
Trial: 2908133
Drug: Ketazolam 15
RxNorm normalized name: ketazolam 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketazolam 15 mg
Trial: 26610167
Drug: Dialogical Exposure
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialogical Exposure Therapy (DET)
Trial: 27817180
Drug: Self-Administered Stress
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-Administered Stress Management Training (SSMT)
Trial: 27817180
Drug: SSMT with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SSMT with psychotropic agent
Trial: 21150199
Drug: Topical methylprednisolone
RxNorm normalized name: methylprednisolone Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical methylprednisolone applied to the round window during cochlear implantation
Trial: 21150199
Drug: Topical methylprednisolone
RxNorm normalized name: methylprednisolone Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical methylprednisolone
Trial: 19730280
Drug: Clonazepam 4
RxNorm normalized name: Clonazepam 400 microgram/mL oral solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam 4 mg
Trial: 17089357
Drug: IL-21 +
RxNorm normalized name: Ile
DrugBank: Isoleucine (DB00167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IL-21 + low-dose IL-2
Trial: 17089357
Drug: IL-15 +
RxNorm normalized name: Ile
DrugBank: Isoleucine (DB00167)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IL-15 + low-dose IL-2
Trial: 15361080
Drug: Rabeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole (20 mg b.i.d.), ofloxacin (400 mg b.i.d.), amoxicillin (1000 mg b.i.d.) for 7 days
Trial: 15361080
Drug: Rabeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole (20 mg b.i.d.), ofloxacin (400 mg b.i.d.), amoxicillin (1000 mg b.i.d.) for 14 days
Trial: 9327336
Drug: Intramuscular immunization
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular immunization
Trial: 8424302
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no calcium channel blocker)
Trial: 28638025
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy exercises on the 3rd, 5th, 7th and 9th days of rehabilitation
Trial: 26244306
Drug: Tenofovir gel
RxNorm normalized name: Tenofovir
DrugBank: Tenofovir (DB14126)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Tenofovir gel (with vaginal concentrations of 10,000 ng/mL or more)
Trial: 23578015
Drug: 1.2 mg/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 mg/kg/day atomoxetine for 20 weeks
Trial: 18812431
Drug: Cortical stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortical stimulation (CS) combined with rehabilitation for 6 weeks, delivered during therapy.
Trial: 18812431
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group receiving the same therapy without device implantation or stimulation.
Trial: 16904298
Drug: Antipsychotic drugs
RxNorm normalized name: Diazepines, oxazepines, thiazepines and oxepines antipsychotic drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotic drugs (haloperidol, risperidone, olanzapine, quetiapine)
Trial: 3552840
Drug: Streptokinase (SK)
DrugBank: Streptokinase (DB00086)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Streptokinase (SK) treatment
Trial: 9578190
Drug: Oral theophylline
RxNorm normalized name: theophylline Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral theophylline 10 mg kg(‐1) day(‐1)
Trial: 7713093
Drug: No oral
RxNorm normalized name: Beano Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No oral anticoagulation (Group II)
Trial: 360120
Drug: Cefazolin (8-hour,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin (8-hour, 3-dose regimen)
Trial: 31159776
Drug: S&G exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S&G exercise intervention (combining supervised exercise with gamification and social incentives via WeChat)
Trial: 31159776
Drug: S&G exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S&G exercise intervention
Trial: 28296334
Drug: Amitriptyline 25
RxNorm normalized name: amitriptyline 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline 25 mg single dose
Trial: 11973484
Drug: 99mTc-DTPA aerosol
RxNorm normalized name: DTPA
DrugBank: Pentetic acid (DB14007)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 99mTc-DTPA aerosol inhalation scintigraphy
Trial: 16865577
Drug: Transdermal estrogen/progestin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal estrogen/progestin
Trial: 16865577
Drug: Transdermal estrogen/progestin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal estrogen/progestin and Placebo
Trial: 11128344
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 150 mg/daily
Trial: 9097868
Drug: High-dose naltrexone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose naltrexone (100 mg bid) followed by 200 mg bid during open-label period
Trial: 3539851
Drug: Prophylactic systemic
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic systemic antibiotics (PSA)
Trial: 26598744
Drug: Lapatinib +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lapatinib + Trastuzumab (L+T)
Trial: 26598744
Drug: Trastuzumab followed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trastuzumab followed by Lapatinib (T->L)
Trial: 23887684
Drug: Oral clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral clonidine premedication followed by intraoperative saline infusion (group A)
Trial: 23887684
Drug: Placebo premedication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo premedication followed by dexmedetomidine infusion (group B)
Trial: 11017811
Drug: Prednisolone, 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone, 60 mg/day for 2 weeks
Trial: 9251115
Drug: Hepatic intra-arterial
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Hepatic intra-arterial (HIA) chemotherapy
Trial: 1609034
Drug: Haloperidol treatment
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Haloperidol treatment with 50% dose decrease
Trial: 3303753
Drug: Intra-arterial infusion
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial infusion of MTX and 5-FU (therapy arm A)
Trial: 3303753
Drug: Systematic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systematic treatment with CMFV combination (therapy arm B)
Trial: 25156082
Drug: Luliconazole cream
RxNorm normalized name: Luliconazole Cream
DrugBank: Luliconazole (DB08933)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Luliconazole cream 1%
Trial: 20332720
Drug: Alcohol injection
RxNorm normalized name: Dehydrated Alcohol Injection Solution
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol injection to the motor branches of tibial nerve
Trial: 20332720
Drug: Phenol injection
RxNorm normalized name: Phenol Injection
DrugBank: Phenol (DB03255)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenol injection to the motor branches of tibial nerve
Trial: 16607468
Drug: Pramipexole (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pramipexole (1.5 to 4.5 mg/day)
Trial: 14615578
Drug: Antidepressant (nefazodone)
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant (nefazodone)
Trial: 14615578
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of antidepressant and psychotherapy
Trial: 455950
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of psychotherapy and pharmacotherapy
Trial: 10524470
Drug: Controlled-release oxycodone
RxNorm normalized name: oxycodone
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Controlled-release oxycodone given every 12 hours
Trial: 10524470
Drug: Immediate-release oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release oxycodone given four times daily
Trial: 9586597
Drug: Alpha-blockers
RxNorm normalized name: ALPHA BLOCKERS/RELATED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha-blockers
Trial: 1975246
Drug: Beta-blockers with
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blockers with concurrent alpha-blocker
Trial: 7009255
Drug: Clomipramine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine (25 mg daily)
Trial: 28719669
Drug: Nutritional supplement
RxNorm normalized name: Nutritional supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional supplement (SUPP; n = 25; 30 g whey protein, 2.5 g creatine, 500 IU vitamin D, 400 mg calcium, 1500 mg n‐3 PUFA)
Trial: 28719669
Drug: Nutritional supplement
RxNorm normalized name: Nutritional supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional supplement (SUPP + EX)
Trial: 28719669
Drug: Control (CON;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (CON; n = 24; 22 g of maltodextrin)
Trial: 11760164
Drug: Clinafloxacin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinafloxacin (200 mg/d)
Trial: 11760164
Drug: Ceftriaxone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone (2 g/d; with or without erythromycin)
Trial: 9408806
Drug: Paroxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (20 mg/day) plus placebo for 4 weeks
Trial: 9408806
Drug: Paroxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (20 mg/day) plus pindolol (7.5 mg/day) for 1 week and placebo for 3 weeks
Trial: 9408806
Drug: Paroxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (20 mg/day) plus pindolol (7.5 mg/day) for 4 weeks
Trial: 9408806
Drug: Paroxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (20 mg/day) plus metoprolol (50 mg/day)
Trial: 23772856
Drug: Ferric carboxymaltose
RxNorm normalized name: Ferric Carboxymaltose
DrugBank: Ferric carboxymaltose (DB08917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ferric carboxymaltose (FCM), 750 mg, two doses, 1 week apart (Group A)
Trial: 23772856
Drug: Ferric carboxymaltose
RxNorm normalized name: Ferric Carboxymaltose
DrugBank: Ferric carboxymaltose (DB08917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ferric carboxymaltose (FCM), 750 mg, two doses, 1 week apart (Group C)
Trial: 23772856
Drug: Oral iron,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron, 325 mg, 3 times a day for 14 days (Group B)
Trial: 20705778
Drug: Ultrasound guidance
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound guidance (UG) with 1.5% mepivacaine, starting dose 13 mL for median nerve
Trial: 20705778
Drug: Neurostimulation (NS)
RxNorm normalized name: NS-2359
DrugBank: NS-2359 (DB05805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neurostimulation (NS) with 1.5% mepivacaine, starting dose 11 mL for ulnar nerve
Trial: 19117154
Drug: Ropivacaine 0.2%
RxNorm normalized name: ROPivacaine 0.2% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 0.2% + sufentanil 0.75 microg mL‐1 (Group-I)
Trial: 8903809
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg ketorolac
Trial: 23943850
Drug: Levamisole hydrochloride
RxNorm normalized name: Levamisole Hydrochloride
DrugBank: Levamisole (DB00848)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levamisole hydrochloride (150 mg)
Trial: 23943850
Drug: No adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No adjuvant to antimalarial treatment (Control)
Trial: 17701094
Drug: Low fluoride
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low fluoride dose (≤20 mg fluoride equivalents)
Trial: 17701094
Drug: Fluoride treatment
RxNorm normalized name: 60 Second 1.23% Fluoride Treatment Dental Gel
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluoride treatment with daily dose >20 mg fluoride equivalents
Trial: 12803658
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (clipping)
Trial: 7912947
Drug: Balanced anaesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balanced anaesthesia with fentanyl (4 micrograms kg‐1 bolus followed by 1 microgram kg‐1 h‐1 infusion)
Trial: 2598976
Drug: Cisapride 10
RxNorm normalized name: cisapride 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 10 mg i.v.
Trial: 20147814
Drug: Serum CTX
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum CTX test performed preoperatively in 54 patients taking oral bisphosphonates (BPs)
Trial: 20147814
Drug: No CTX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No CTX test performed in 109 patients taking oral BPs (control group)
Trial: 15669886
Drug: Paroxetine CR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine CR (25-75 mg/day)
Trial: 9257379
Drug: Tretinoin cream
RxNorm normalized name: Tretinoin Cream
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tretinoin cream 0.025%
Trial: 12889719
Drug: Tretinoin microsphere
RxNorm normalized name: tretinoin microsphere
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tretinoin microsphere gel 0.1%
Trial: 12963899
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of adapalene gel 0.1% with various antimicrobial agents
Trial: 9234040
Drug: 24-hr patch
RxNorm normalized name: 24 Hour Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-hr patch
Trial: 9234040
Drug: 16-hr patch
RxNorm normalized name: nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 16-hr patch
Trial: 9234040
Drug: 24-hr patch
RxNorm normalized name: 24 Hour Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-hr patch plus gum
Trial: 9234040
Drug: Double 24-hr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double 24-hr patch
Trial: 7961259
Drug: Inspiratory flow-resistive
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein Injection [Arexvy]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inspiratory flow-resistive loading (L2: 125 cmH2O.l‐1.s)
Trial: 7961259
Drug: Inspiratory flow-resistive
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein Injection [Arexvy]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inspiratory flow-resistive loading (L3: 250 cmH2O.l‐1.s)
Trial: 3475725
Drug: Intra-amniotic 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-amniotic 1.5 mg 15(S) 15 methyl PGF2 alpha (PGF2 alpha)
Trial: 3475725
Drug: Indomethacin 25
RxNorm normalized name: indomethacin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 25 mg and 50 mg orally three and one hour before PGF2 alpha
Trial: 2076744
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal suspension (5 g as 200 ml)
Trial: 2076744
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal tablets (40 of 125 mg)
Trial: 2076744
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal capsules (25 of 200 mg)
Trial: 2076744
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment (suspension medium without AC)
Trial: 1215547
Drug: Indomethacin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (50 mg X 4 over 24 hours)
Trial: 1215547
Drug: Indomethacin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (50 mg X 6 over 36 hours)
Trial: 26978624
Drug: Advanced techniques
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advanced techniques including minimally invasive surgical sanitation of infected fracture zone followed by differentiated tactics of consistent and gradual minimally invasive functionally stable osteosynthesis with modern APS and implants on a background of conservative therapy consisting of Cycloferon.
Trial: 23888318
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (2 g/day)
Trial: 23888318
Drug: High-oleic sunflower
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-oleic sunflower oil (8 g/day)
Trial: 23888318
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (2 g/day) and High-oleic sunflower oil (8 g/day)
Trial: 15536111
Drug: DHEA 50
RxNorm normalized name: Natrol Mood & Stress DHEA 50mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA 50 mg/d for 6 months
Trial: 11238151
Drug: 0.97 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.97 mg/kg amphotericin B by continuous infusion over 24 hours
Trial: 11238151
Drug: 0.95 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.95 mg/kg amphotericin B by rapid infusion over four hours
Trial: 30543461
Drug: Domperidone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone (10 mg thrice daily for 14 days)
Trial: 27484978
Drug: Aerobic exercise
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerobic exercise plus pharmacotherapy
Trial: 27484978
Drug: Only pharmacotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Only pharmacotherapy
Trial: 26033708
Drug: Maintenance chemotherapy
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance chemotherapy with paclitaxel plus gemcitabine (PG)
Trial: 24717377
Drug: Pharmacotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacotherapy with sertraline
Trial: 22007522
Drug: Lisinopril/hydrochlorothiazide combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril/hydrochlorothiazide combined tablets (high, medium, low doses)
Trial: 22007522
Drug: Repeated administration
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated administration of lisinopril/hydrochlorothiazide combined tablets
Trial: 22007522
Drug: Lisinopril (test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril (test medication)
Trial: 22007522
Drug: Hydrochlorothiazide (test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (test medication)
Trial: 8620790
Drug: Sublingual nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual nifedipine 20 mg
Trial: 6381432
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous infusions of BUdR and IUdR